However, six were upstaged, five as stage IV disease (one contral

However, six were upstaged, five as stage IV disease (one contralateral chest, two selleck screening library contralateral chest and

abdomen, two abdomen) and one as mediastinal node positive; two further patients were reclassified histologically (one sarcomatoid, one biphasic). These eight patients fared poorly, 50% dying within 1 year from mesothelioma. Following surgical staging, 3 patients declined further surgery; thus, 19 patients proceeded to surgery, 3 were unresectable and 16 received EPP. Follow-up of all 34 patients is complete.\n\nConclusion: Surgical staging identified 26% of patients who would have received no benefit from TMT.”
“Background and Objectives: Transforming growth factor-beta 1 (TGF-beta 1) and CD14 play pivotal roles in the pathogenesis of asthma. This study aimed to evaluate the effects of TGF-beta 1 single nucleotide polymorphisms (SNPs) on asthma risk and asthma-related phenotypes and gene-gene interactions with CD14 in a Chinese Han Population.\n\nMethods: We consecutively recruited 318 unrelated adult asthmatic patients and 352 healthy volunteers. Genotyping of each selected AR-13324 SNP in TGF-beta 1 and CD14 was performed using SNP-stream

and TaqMan SNP genotyping technology. We conducted case-control and case-only association studies between the selected SNPs and asthma or asthma-related phenotypes. Multivariate logistic regression analysis was applied to detect the gene-gene interactions.\n\nResults: Neither the alleles nor the genotypes of the 3 TGF-beta 1 SNPs (i.e. rs1800469, rs1982073 and rs12983047) and CD14 SNP rs2563298 were found to be associated with asthma risk separately. However, the frequency of TGF-beta 1 rs1800469 A769662 TT genotype was significantly lower

in asthmatic patients with CD14 rs2563298 CA or AA genotype (adjusted OR = 0.19, 95%CI = 0.07-0.55, P<0.001), which indicated significant gene-gene interactions between the TGF-beta 1 rs1800469 and the CD14 rs2563298 (adjusted OR = 8.23, 95%CI = 2.68-25.30, P<0.001). Such interactions were also found between rs1982073 and rs2563298. An evidently positive association was observed between the TGF-beta 1 SNPs and the percentage of CD4(+)CD25(high)LAP(+) T cells in asthmatic peripheral blood.\n\nConclusion: Polymorphisms in TGF-beta 1 have an effect on the risk of asthma in a Chinese Han population via gene-gene interactions with CD14.”
“Purpose: To compare the efficacy of computer-aided dosing using Coagclinic (a web-based software) with physician dosing in patients receiving warfarin for various cardiac indications. Methods: In order to calculate the effectiveness of physician managed anticoagulation dosing, we calculated the “percentage of time international normalized ratio, INR, was in the therapeutic range” (TTR) for a random sample of 70 patients in the center. For each patient, 4 INR values were taken at 4 consecutive visits, before and after the installation of Coagclinic.

Comments are closed.